{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:48:33Z","timestamp":1792432113712,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Third-generation cephalosporins (3<jats:sup>rd<\/jats:sup> GCs) have recently become controversial as the first-line strategy for empirical spontaneous bacterial peritonitis (SBP) treatment. This study aimed to identify SBP treatment efficacy predictors of 3<jats:sup>rd<\/jats:sup> GCs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this retrospective cohort study, 279 cirrhosis patients with SBP who received 3<jats:sup>rd<\/jats:sup> GC monotherapy for initial empirical treatment from 2013 to 2019 were included. Nonresponse was defined as a decreased ascites polymorphonuclear (PMN) count &lt; 25% from baseline after 48 hours of antibacterial treatment. Multivariate regression analysis was used to identify efficacy predictors of 3<jats:sup>rd<\/jats:sup> GCs in treating SBP. Kaplan\u2013Meier analysis was used to evaluate survival data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The nonresponder group included 120 patients with no response, and the responder group included 159 patients with responses. The response rate to 3<jats:sup>rd<\/jats:sup> GCs was 57.0% among all patients. The common pathogens were <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic> (40.6%), <jats:italic toggle=\"yes\">Staphylococcus<\/jats:italic> (15.6%), <jats:italic toggle=\"yes\">Klebsiella pneumonia<\/jats:italic> (12.5%), and <jats:italic toggle=\"yes\">Streptococcus<\/jats:italic> (12.5%) in 32 ascites culture isolates. Nosocomial SBP (NSBP) (odds ratio [OR]: 2.371, 95% confidence interval [CI]: 1.323\u20134.249, <jats:italic toggle=\"yes\">P<\/jats:italic> = .004), pneumonia (OR: 11.561, 95% CI: 1.876\u201371.257, <jats:italic toggle=\"yes\">P<\/jats:italic> = .008), recurrent SBP (OR: 3.386, 95% CI: 1.804\u20136.357, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), platelet count (\u2265113.5\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L) (OR: 3.515, 95% CI: 1.973\u20136.263, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001), and ascites PMN count (\u22640.760\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L) (OR: 4.967, 95% CI: 2.553\u20139.663, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001) were independent predictors of nonresponse to 3<jats:sup>rd<\/jats:sup> GCs against SBP. Survival plot analysis at 30 days showed worse survival for the nonresponders (<jats:italic toggle=\"yes\">P<\/jats:italic> = .003).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>NSBP, pneumonia, recurrent SBP, increased platelet count, and lower ascites PMN count were independent predictors of nonresponse to 3<jats:sup>rd<\/jats:sup> GC in treating SBP. Nonresponse to initial antibiotic treatment was associated with worse survival.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000030164","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:24:13Z","timestamp":1665415453000},"page":"e30164","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy predictors of third-generation cephalosporins in treating spontaneous bacterial peritonitis"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-6195","authenticated-orcid":false,"given":"Long-Chuan","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Liver Disease, The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Digestion, Children\u2019s Hospital of Jiangxi Province, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Liver Disease, The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Kai","family":"Gan","sequence":"additional","affiliation":[{"name":"Department of Liver Disease, The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Liver Disease, The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Information Technology, The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo-Long","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Liver Disease, The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0168-8278(05)80280-6","article-title":"A prospective study of bacterial infections in patients with cirrhosis.","volume":"18","author":"Caly","year":"1993","journal-title":"J Hepatol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"159","DOI":"10.5152\/tjg.2015.4829","article-title":"The long-term mortality of spontaneous bacterial peritonitis in cirrhotic patients: a 3-year nationwide cohort study.","volume":"26","author":"Hung","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/MEG.0000000000001111","article-title":"Predicting mortality in patients with spontaneous bacterial peritonitis using routine inflammatory and biochemical markers.","volume":"30","author":"Iliaz","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MEG.0000000000001057","article-title":"Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.","volume":"30","author":"Fiore","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.3748\/wjg.v23.i25.4654","article-title":"Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: a systematic review.","volume":"23","author":"Fiore","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4254\/wjh.v9.i30.1166","article-title":"Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis.","volume":"9","author":"Fiore","year":"2017","journal-title":"World J Hepatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3748\/wjg.14.2757","article-title":"Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice.","volume":"14","author":"Angeloni","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial.","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/apt.13539","article-title":"Letter: the emergence of multi-drug resistant spontaneous bacterial peritonitis: a new challenge for the hepatologist?","volume":"43","author":"Fiore","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3748\/wjg.v19.i8.1271","article-title":"Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis.","volume":"19","author":"Badawy","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.mayocp.2018.12.036","article-title":"Prevalence and predictors of third-generation cephalosporin resistance in the empirical treatment of spontaneous bacterial peritonitis.","volume":"94","author":"Sunjaya","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/liv.13015","article-title":"Management of uninfected and infected ascites in cirrhosis.","volume":"36","author":"Sol\u00e0","year":"2016","journal-title":"Liver Int"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices.","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5114\/ceh.2019.85073","article-title":"Risk factors predicting nosocomial, healthcare- associated and community-acquired infection in spontaneous bacterial peritonitis and survival outcome.","volume":"5","author":"Jain","year":"2019","journal-title":"Clin Exp Hepatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2014\/429536","article-title":"Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies.","volume":"28","author":"Chaulk","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s10620-018-4990-y","article-title":"Mortality from spontaneous bacterial peritonitis among hospitalized patients in the USA.","volume":"63","author":"Niu","year":"2018","journal-title":"Dig Dis Sci"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3349\/ymj.2012.53.2.328","article-title":"Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial.","volume":"53","author":"Kim","year":"2012","journal-title":"Yonsei Med J"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.33314\/jnhrc.v16i41.1673","article-title":"Thrombocytosis as a predictor of serious bacterial infection in febrile infants.","volume":"16","author":"Mishra","year":"2019","journal-title":"J Nepal Health Res Counc"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e26928","DOI":"10.1371\/journal.pone.0026928","article-title":"Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection.","volume":"6","author":"Johansson","year":"2011","journal-title":"PLoS One"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3109\/00365521.2013.832367","article-title":"Polymorphonuclear counts in ascitic fluid and microorganisms producing spontaneous bacterial peritonitis: an under-recognized relationship.","volume":"48","author":"Ariza","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/315742","article-title":"In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease.","volume":"182","author":"Fiuza","year":"2000","journal-title":"J Infect Dis"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"46025","DOI":"10.1038\/srep46025","article-title":"Nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis in China: comparative microbiology and therapeutic implications.","volume":"7","author":"Shi","year":"2017","journal-title":"Sci Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:41:03Z","timestamp":1746333663000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000030164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":24,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000030164","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}